| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/18/2011 | CN102066320A Aryl ketone as MRI |
| 05/18/2011 | CN102066319A Processes useful for the synthesis of (R)-1-{2-[4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine |
| 05/18/2011 | CN102060744A Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 05/18/2011 | CN102060743A Method for preparing N-benzyl-3-pyrrolidone |
| 05/18/2011 | CN102060643A Preparation method of N-aryl amino acid |
| 05/18/2011 | CN101709046B Synthetic method of N-methyl-2-chloroethyl pyrrolidine |
| 05/18/2011 | CN101643442B Seaweed bromphenol urea compounds, preparation method and application thereof |
| 05/18/2011 | CN101575309B Method for synthesizing (S)-oxiracetam |
| 05/18/2011 | CN101333180B Method for preparing levetiracetam intermediate |
| 05/18/2011 | CN101242829B Pharmaceutical composition comprising PPAR regulator |
| 05/18/2011 | CN101186611B Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/18/2011 | CN101146530B 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 05/17/2011 | US7943787 Preparation of pentafluorosulfanyl (SF5) heterocycles: pyrroles and thiophenes |
| 05/17/2011 | US7943786 Process for preparing amorphous (4R-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 05/17/2011 | US7943783 Having an acylsulfonamide amine-reactive groups; crosslinker for amine containing material such as gel and hydrgels |
| 05/17/2011 | US7943660 Inhibitors of the LFA-1/ICAM-1 interaction and uses thereof |
| 05/17/2011 | US7943659 cancerous hyperproliferative disorders; 5-Acetyl-2-(2-fluoro-4-iodo-phenylamino)-1H-pyrrole-3-carboxylic acid; 2-acetyl-5-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1-methyl-1H-imidazole-4-carboxamide |
| 05/17/2011 | US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss |
| 05/17/2011 | US7943614 Carboxamide compound and use of the same |
| 05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/17/2011 | US7943388 Acoustic sensors and methods |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/12/2011 | WO2011056895A1 Ionic liquids comprising heteraromatic anions |
| 05/12/2011 | WO2011054888A1 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 05/12/2011 | WO2011054714A1 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides |
| 05/12/2011 | WO2011005969A3 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/12/2011 | US20110112309 Preparation process useful in synthesis of atorvastatin |
| 05/12/2011 | US20110112304 Carbene Complexes of Lithium And/Or Magnesium Metal Salts, And Uses Thereof |
| 05/12/2011 | US20110112282 Ido inhibitors and therapeutic uses thereof |
| 05/12/2011 | US20110112165 Atorvastatin-aliskiren |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112066 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/12/2011 | US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
| 05/12/2011 | US20110111994 Process for the preparation of polyalkenyl succinic anhydrides |
| 05/12/2011 | US20110111519 Reagent for detecting an analyte |
| 05/12/2011 | US20110111477 Long acting formulation of biopharmaceutical |
| 05/12/2011 | US20110111068 Inhibitors of cognitive decline |
| 05/12/2011 | US20110110858 Gold nanoparticle imaging agents and uses thereof |
| 05/12/2011 | US20110108765 Polymerizable optically active imide compound and polymerizable composition containing the compound |
| 05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
| 05/12/2011 | CA2780040A1 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 05/12/2011 | CA2779785A1 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides |
| 05/11/2011 | EP2319843A1 Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| 05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 05/11/2011 | EP2318568A1 Corrosion inhibitors having increased biological degradability and minimized toxicity |
| 05/11/2011 | EP2318364A2 Preparation of 3-pyrrole substituted 2-indolinone derivatives |
| 05/11/2011 | EP2318363A1 Heterocyclic derivatives as iap binding compounds |
| 05/11/2011 | EP2318362A2 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 05/11/2011 | EP2318361A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/11/2011 | EP2318006A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/11/2011 | EP1861364B1 Preparation of an atorvastatin intermediate using a paal-knorr condensation |
| 05/11/2011 | EP1606254B1 2,4,6-phenyl substituted cyclic ketoenols |
| 05/11/2011 | CN1906181B N-sulfonylaminocarbonyl containing compounds |
| 05/11/2011 | CN1882535B Process for preparing 2-oxo-1-pyrrolidine derivatives |
| 05/11/2011 | CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 05/11/2011 | CN102050776A 5-substituted methylpyrrolidine-2, 4-diketone compound and use thereof |
| 05/11/2011 | CN102050775A Anastrozole impurity alpha, alpha, alpha', alpha'-tetramethyl-5-(succinimide-1-methyl)-1,3-phenyl diacetonitrile and preparation method thereof |
| 05/11/2011 | CN102050774A Oxiracetam compound and new method thereof |
| 05/11/2011 | CN102050747A Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis |
| 05/11/2011 | CN101735132B Synthesis method of N-methyl-2-hydroxyethyl hydroxyethyl |
| 05/11/2011 | CN101684088B Cyanomethyl pyrrole derivative and preparation method and application thereof |
| 05/11/2011 | CN101177370B Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939676 Process for the preparation of levetiracetam |
| 05/10/2011 | US7939675 dissolving atorvastatin in a nonalcoholic solvent such as dimethylsulfoxide to form a solution; and lyophilizing the solution to form amorphous atorvastatin |
| 05/10/2011 | US7939666 Enzyme inhibitors |
| 05/10/2011 | US7939657 N-substituted benzene sulfonamides |
| 05/10/2011 | US7939513 Tetracycline derivatives as antibacterial agents |
| 05/10/2011 | CA2573771C Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .gamma.-dihydroxy-5-(1-menthylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | US20110105758 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroarylcarbocyclic acids |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105568 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105565 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 05/05/2011 | US20110105554 Means for treating myosin-related diseases |
| 05/05/2011 | US20110105488 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110104057 Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315747A2 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2315591A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/04/2011 | EP2315590A1 Pyrrole inhibitors of s-nitrosoglutathione reductase |
| 05/04/2011 | EP2155669B1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 05/04/2011 | EP2035373B1 Phenyl pyrrole aminoguanidine derivatives |
| 05/04/2011 | EP1867656B1 Compound having cyclic structure and use thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | CN102046598A Novel donor-acceptor fluorene scaffolds : a process and uses thereof |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102040549A Statin compound, preparation method and medicament application thereof in blood fat regulation |
| 05/04/2011 | CN102040521A Polymerizable compound |
| 05/04/2011 | CN101474578B Method of separating imide compound |
| 05/04/2011 | CN101142181B Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives |